Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

In vivo brain imaging of human exposure to nicotine and tobacco.

Sharma A, Brody AL.

Handb Exp Pharmacol. 2009;(192):145-71. doi: 10.1007/978-3-540-69248-5_6. Review.

2.

Functional brain imaging of tobacco use and dependence.

Brody AL.

J Psychiatr Res. 2006 Aug;40(5):404-18. Epub 2005 Jun 24. Review.

3.

Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.

Brody AL, Mandelkern MA, Olmstead RE, Allen-Martinez Z, Scheibal D, Abrams AL, Costello MR, Farahi J, Saxena S, Monterosso J, London ED.

Neuropsychopharmacology. 2009 Jan;34(2):282-9. doi: 10.1038/npp.2008.87. Epub 2008 Jun 18.

4.

Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.

Brody AL, Mandelkern MA, Costello MR, Abrams AL, Scheibal D, Farahi J, London ED, Olmstead RE, Rose JE, Mukhin AG.

Int J Neuropsychopharmacol. 2009 Apr;12(3):305-16. doi: 10.1017/S146114570800922X. Epub 2008 Aug 18.

5.

Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.

Jasinska AJ, Zorick T, Brody AL, Stein EA.

Neuropharmacology. 2014 Sep;84:111-22. doi: 10.1016/j.neuropharm.2013.02.015. Epub 2013 Mar 6. Review.

6.

Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.

Brody AL, Mukhin AG, Mamoun MS, Luu T, Neary M, Liang L, Shieh J, Sugar CA, Rose JE, Mandelkern MA.

JAMA Psychiatry. 2014 Jul 1;71(7):797-805. doi: 10.1001/jamapsychiatry.2014.138.

7.

Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.

Scott DJ, Domino EF, Heitzeg MM, Koeppe RA, Ni L, Guthrie S, Zubieta JK.

Neuropsychopharmacology. 2007 Feb;32(2):450-7. Epub 2006 Nov 8.

8.

Mechanism-based medication development for the treatment of nicotine dependence.

Xi ZX, Spiller K, Gardner EL.

Acta Pharmacol Sin. 2009 Jun;30(6):723-39. doi: 10.1038/aps.2009.46. Epub 2009 May 11. Review.

9.

Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus.

Alkondon M, Pereira EF, Almeida LE, Randall WR, Albuquerque EX.

Neuropharmacology. 2000 Oct;39(13):2726-39.

PMID:
11044743
10.

Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms.

Howe WM, Ji J, Parikh V, Williams S, Mocaër E, Trocmé-Thibierge C, Sarter M.

Neuropsychopharmacology. 2010 May;35(6):1391-401. doi: 10.1038/npp.2010.9. Epub 2010 Feb 10.

11.

Magnetic resonance imaging studies of cigarette smoking.

Azizian A, Monterosso J, O'Neill J, London ED.

Handb Exp Pharmacol. 2009;(192):113-43. doi: 10.1007/978-3-540-69248-5_5. Review.

PMID:
19184648
12.

Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.

Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M, Zanardi A, Rimondini R, Mugnaini M, Clementi F, Chiamulera C, Zoli M.

J Neurosci. 2010 Apr 14;30(15):5311-25. doi: 10.1523/JNEUROSCI.5095-09.2010.

13.

Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers.

Staley JK, Krishnan-Sarin S, Cosgrove KP, Krantzler E, Frohlich E, Perry E, Dubin JA, Estok K, Brenner E, Baldwin RM, Tamagnan GD, Seibyl JP, Jatlow P, Picciotto MR, London ED, O'Malley S, van Dyck CH.

J Neurosci. 2006 Aug 23;26(34):8707-14.

14.
15.

Sex differences in nicotine action.

Pogun S, Yararbas G.

Handb Exp Pharmacol. 2009;(192):261-91. doi: 10.1007/978-3-540-69248-5_10. Review.

PMID:
19184653
16.

Nicotine addiction: the possible role of functional upregulation.

Buisson B, Bertrand D.

Trends Pharmacol Sci. 2002 Mar;23(3):130-6. Review.

PMID:
11879680
17.

Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.

Hussmann GP, Turner JR, Lomazzo E, Venkatesh R, Cousins V, Xiao Y, Yasuda RP, Wolfe BB, Perry DC, Rezvani AH, Levin ED, Blendy JA, Kellar KJ.

J Pharmacol Exp Ther. 2012 Nov;343(2):441-50. doi: 10.1124/jpet.112.198085. Epub 2012 Aug 16.

18.

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.

Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE.

Neuropharmacology. 2007 Mar;52(3):985-94. Epub 2006 Dec 8.

PMID:
17157884
19.

Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.

Perez XA, McIntosh JM, Quik M.

J Neurochem. 2013 Dec;127(6):762-71. doi: 10.1111/jnc.12442. Epub 2013 Oct 13.

20.

Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers.

Esterlis I, Hannestad JO, Perkins E, Bois F, D'Souza DC, Tyndale RF, Seibyl JP, Hatsukami DM, Cosgrove KP, O'Malley SS.

Am J Psychiatry. 2013 Apr;170(4):399-407. doi: 10.1176/appi.ajp.2012.12060793.

Supplemental Content

Support Center